tldrdailynews.com logo

Viking Therapeutics Shares Drop 40% Amidst Weight-Loss Trial Failures

1 min read
Source: Bloomberg
Viking Therapeutics Shares Drop 40% Amidst Weight-Loss Trial Failures
Photo: Bloomberg
TL;DR

Viking Therapeutics experienced its worst stock decline on record, leading short sellers to profit $521 million, after a mid-stage study of its obesity pill showed significant side effects, undermining investor confidence despite analyst optimism and high price targets.

Topics:business#business#market-reaction#obesity-pill#shorts#stock-decline#viking-therapeutics
Share this article
  1. Viking Therapeutics Shorts Reap $514 Million as Stock Falls 40%  Bloomberg
  2. Viking Therapeutics stock crashes after weight-loss pill trial shows high dropout rate  Yahoo Finance
  3. Viking Therapeutics shares fall 40% on disappointing obesity pill trial data  CNBC
  4. High drop-out rate clouds weight loss data for Viking's oral drug  FirstWord Pharma
  5. This Weight-Loss Stock Is Down 40%. It Lowers the Risks for Eli Lilly and Novo Nordisk.  Barron's

Want the full story? Read the original reporting

Read on Bloomberg